Amgen to Buy Horizon for $28B in the Year’s Biggest Pharma Takeover
Amgen plans to buy Horizon Therapeutics for about $28 billion in cash, bringing on board two blockbuster drugs to ease the hit the biotech giant faces from biosimilar competition.
The companies announced the deal in a press release Monday morning, about two weeks after it was disclosed that Amgen, Sanofi and Johnson & Johnson’s Janssen were all in talks. Amgen struck the deal after agreeing to pay $116.50, a 48% premium over Horizon’s price, before the talks became public on Nov. 29.
Read the full article at: endpts.com
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.